Five9 Insider Sales: Dignan Sells Shares Under 10b5-1 Plan
Rhea-AI Filing Summary
Five9, Inc. reporting person Andy Dignan sold shares on 09/04/2025 and 09/05/2025. The transactions include three non-derivative sales: 3,402 shares sold on 09/04/2025 at a weighted average price of $25.72, 4,212 shares sold on 09/04/2025 at a weighted average price of $25.28, and 700 shares sold on 09/05/2025 at $26.48. After these sales, the reporting person beneficially owned 217,425 shares.
The filing states the 09/04/2025 sales were mandated by Five9 to cover tax withholding on vested restricted stock units, and the 4,212-share and 700-share sales were effected under a Rule 10b5-1 trading plan adopted December 10, 2024. The form is signed by an attorney-in-fact on behalf of the reporting person.
Positive
- Sales were executed under a Rule 10b5-1 trading plan adopted 12/10/2024, indicating pre-planned transactions
- Company-mandated sale to cover tax withholding on RSU vesting reduces likelihood these were discretionary insider trades
Negative
- None.
Insights
TL;DR: Insider sold shares largely to cover tax obligations; sales executed under a 10b5-1 plan indicate pre-planned disposition.
The Form 4 discloses routine insider selling: mandated broker sales to satisfy tax withholding on vested restricted stock units and additional sales executed pursuant to a Rule 10b5-1 plan adopted 12/10/2024. The filing provides specific share counts and weighted-average prices for the transactions, and reports remaining beneficial ownership at 217,425 shares. From an investor-information perspective, these disclosures are procedural rather than indicative of a change in corporate performance or governance. The filing commits to provide detailed per-trade price breakdowns upon request, which supports transparency.
TL;DR: Transactions appear compliant and administrative; use of 10b5-1 and company-mandated tax-withholding sales are standard practice.
The report documents compliance mechanisms: company-mandated sales to satisfy tax liabilities on RSU vesting and sales under a pre-established 10b5-1 trading plan. Such actions typically reduce the risk of ad-hoc insider trading concerns. The signature by an attorney-in-fact is noted, and the filer offers to provide granular pricing information on request. There is no indication in the form of discretionary opportunistic sales tied to nonpublic developments.
FAQ
What shares did Andy Dignan sell according to the Form 4 for FIVN?
Why were the shares sold in the Form 4 filed for FIVN?
What prices were reported for the sales in the Form 4 for FIVN?
How many Five9 shares did the reporting person own after the reported transactions?
When was the 10b5-1 plan adopted as noted in the Form 4 for FIVN?